Tevogen Bio (TVGN) shares jumped 74% in recent Wednesday trading after the company said its artificial intelligence project Tevogen AI has joined Microsoft (MSFT) for Startups.
The partnership will provide Tevogen with "access to Microsoft's extensive ecosystem," the company said, adding it will accelerate the development of Tevogen's proprietary algorithms to advance drug development and discovery.
Price: 2.82, Change: +1.21, Percent Change: +75.09
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.